Navigation Links
Webcast Alert: Isis Pharmaceuticals Hosts Expert Panel Conference Call to Discuss Mipomersen Data Presented at the ESC Congress 2010
Date:8/30/2010

CARLSBAD, Calif., Aug. 30 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announces the following webcast:What:

Data from mipomersen Phase 3 trial in heFH patients presented at ESCWhen:

Wednesday, September 1, 2010 at 4:00 p.m. ET / 1:00 p.m. PTWhere:

www.isispharm.comHow:

Live on the Internet.  Simply log onto our Web site listed above. If you are unable to participate during the live event, a replay of the webcast will be available for a limited time at www.isispharm.com.

ABOUT ISIS PHARMACEUTICALS, INC.Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners.  The Company has successfully commercialized the world's first antisense drug and has 23 drugs in development.  Isis' drug development programs are focused on treating cardiovascular, metabolic, and severe neurodegenerative diseases and cancer.  Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases.  Isis and Alnylam Pharmaceuticals are joint owners of Regulus Therapeutics Inc., a company focused on the discovery, development and commercialization of microRNA therapeutics.  Isis also has made significant innovations beyond human therapeutics resulting in products that other companies, including Abbott, are commercializing.  As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,600 issued patents worldwide.  Additional information about Isis is available at www.isispharm.com.


'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Advanced Life Sciences to Host Second Quarter 2010 Conference Call and Live Webcast
2. Volcano Corporation Presentation at Canaccord Genuity Growth Conference to be Webcast
3. Medivation Announces Second Quarter 2010 Financial Results Teleconference and Webcast on August 9, 2010
4. Orexigen® Therapeutics Schedules August 5, 2010 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2010
5. Amicus Therapeutics to Host Its Second Quarter 2010 Financial Results Conference Call and Webcast on August 5, 2010
6. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide a Clinical Update on Carfilzomib
7. Thoratec Schedules Second Quarter Conference Call, Webcast
8. Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2010 Financial Results
9. Kendle Announces Details Regarding Second Quarter 2010 Earnings Conference Call and Webcast
10. Mylan Schedules Second Quarter 2010 Financial Results Conference Call and Live Webcast
11. Watson to Host Conference Call and Webcast to Discuss Second Quarter 2010 Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... April 28, 2016 TapImmune,Inc. ... innovative peptide and gene-based immunotherapeutics and vaccines for the treatment ... presenting at the 3rd Annual Growth Capital Expo ... , 2016 at Caesars Palace in Las Vegas, Nevada.  ... Wednesday, May 4 th by Dr. John N. ...
(Date:4/27/2016)... Avril 2016   ... +5% sur le trimestre, soutenu par une croissance ... Croissance de +16% des ventes aux hôpitaux ... Kea Technologies (Euronext : MKEA, FR0010609263 ; OTCQX : MKEAY), inventeur ... aujourd,hui son chiffre d,affaires pour le premier trimestre ...
(Date:4/27/2016)... , April 27, 2016   Zillion ... digital health technology platform, which specializes in live ... into scalable digital products, Zillion enables companies to ... empower consumers to take control of their health. ... video conferencing – including one-to-one, group and webcast ...
Breaking Medicine Technology:
(Date:4/29/2016)... MO (PRWEB) , ... April 29, 2016 , ... International ... Technology Seminar on May 3 and 4 at the Doubletree by Hilton Hotel in ... is dedicated to marketing and applications technologies for protein ingredients. , At the seminar, ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Society for Assisted ... endocrinologists are required to report in vitro fertilization (IVF) delivery rates ... the practice of assisted reproductive technologies in the United States. , This ...
(Date:4/29/2016)... ... April 29, 2016 , ... Orthodontics Limited, ... founders, Dr. Gemmi and Dr. Middleberg, were asked by Invisalign to ... During the seminar, titled “Advancing the Biomechanics of Invisalign Clear Aligners,” Dr. ...
(Date:4/28/2016)... ... April 28, 2016 , ... ProText Layouts is a set of 30 ... . With ProText Layouts, video editors can create an energetic typography video with ... scale of texts. Creating text-based videos have never been easier. , ProText Layouts ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... today the open availability of a new CDISC standard, Clinical Trial Registry ... clinical trials. This innovative standard will make it possible to build applications ...
Breaking Medicine News(10 mins):